TNFSF18 anticorps
Aperçu rapide pour TNFSF18 anticorps (ABIN1169328)
Antigène
Voir toutes TNFSF18 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- Recognizes human GITRL. Detects a band of ~15-17 kDa by Western blot.
-
Réactivité croisée
- Humain
-
Aucune reactivité croisée
- Souris
-
Réactivité croisée (Details)
- Does not cross-react with mouse GITRL.
-
Stérilité
- 0.2 μm filtered
-
Immunogène
- Recombinant human GITRL.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives.
-
Agent conservateur
- Without preservative
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
-
Short Term Storage: +4°C
Long Term Storage: -20°C
Stable for at least 6 months after receipt when stored at -20°C. -
Date de péremption
- 6 months
-
-
- TNFSF18 (Tumor Necrosis Factor (Ligand) Superfamily, Member 18 (TNFSF18))
-
Autre désignation
- GITRL
-
Sujet
- GITRL is expressed on dendritic cells (DC), monocytes, macrophages, B cells, activated T cells, endothelial cells, osteoclasts and various healthy non-lymphoid tissues (e.g. testis, ..). GITRL is constitutively expressed and released as soluble form by solid tumors and various hematopoietic malignancies. GITRL causes differentiation of osteoclasts, activation of macrophages, but also alteration of carcinoma and leukemia cells and influences apoptosis. Binding to GITR is important in regulating T-cell proliferation and TCR-mediated apoptosis. GITRL is implicated in development of autoimmune diseases and in the immune response against infectious pathogens and tumors.
-
UniProt
- Q9UNG2
Antigène
-